43769 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.
Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.
| When | Stock | Change | Analyst | Rating | Price Target |
|---|---|---|---|---|---|
|
Aug 12
12:08 UTC
|
BLTE
Belite Bio
|
◎ Target | Yi Chen ★★★☆☆ #1732 | Buy | $200.00→ $214.00+7.0% |
|
Aug 12
12:08 UTC
|
BCAX
Bicara Therapeutics
|
◎ Target | Jeet Mukherjee ★★☆☆☆ #2364 | Buy | $28.00→ $39.00+39.3% |
|
Aug 12
12:08 UTC
|
ARMK
Aramark
|
◎ Target | Andrew Wittmann ★★★★☆ #356 | Outperform | $63.00→ $69.00+9.5% |
|
Aug 12
12:08 UTC
|
APP
AppLovin
|
◎ Target | Clark Lampen ★★★☆☆ #1814 | Buy | $574.00→ $408.00-28.9% |
|
Aug 12
12:08 UTC
|
AMTM
Amentum
|
◎ Target | Andre Madrid ★★★☆☆ #1026 | Buy | $35.00→ $30.00-14.3% |
|
Aug 12
12:08 UTC
|
AMBQ
Ambiq Micro
|
◎ Target | N. Quinn Bolton not yet tracked | Buy | $70.00→ $85.00+21.4% |
|
Aug 12
12:08 UTC
|
AFRM
Affirm
|
◎ Target | Rufus Hone not yet tracked | Outperform | $78.00→ $86.00+10.3% |
|
Aug 12
12:08 UTC
|
ACAD
ACADIA Pharmaceuticals
|
◎ Target | Ami Fadia ★★☆☆☆ #2557 | Buy | $38.00→ $41.00+7.9% |
|
Aug 12
11:18 UTC
|
ULVR
Unilever
|
◎ Target | firm only | Underperform | GBX 3,800→ GBX 3,900+2.6% |
|
Aug 12
11:18 UTC
|
TW
Taylor Wimpey
|
◎ Target | firm only | Buy | GBX 102→ GBX 101-1.0% |
|
Aug 12
11:18 UTC
|
SHC
Shaftesbury Capital
|
◎ Target | firm only | Buy | GBX 185→ GBX 195+5.4% |
|
Aug 12
11:18 UTC
|
PSN
Persimmon
|
◎ Target | firm only | Buy | GBX 1,591→ GBX 1,590-0.1% |
|
Aug 12
11:18 UTC
|
GEN
Genuit Group
|
◎ Target | firm only | Buy | GBX 332→ GBX 366+10.2% |
|
Aug 12
11:18 UTC
|
DRX
Drax Group
|
◎ Target | firm only | Buy | GBX 920→ GBX 870-5.4% |
|
Aug 12
11:18 UTC
|
BWY
Bellway
|
◎ Target | firm only | Buy | GBX 2,394→ GBX 2,380-0.6% |
|
Aug 12
09:55 UTC
|
STJ
St. James's Place
|
◎ Target | firm only | Buy | GBX 1,830→ GBX 1,820-0.5% |
|
Aug 12
09:55 UTC
|
SPX
Spirax-Sarco Engineering
|
◎ Target | firm only | Neutral | GBX 7,800→ GBX 8,600+10.3% |
|
Aug 12
09:55 UTC
|
OCDO
Ocado Group
|
◎ Target | firm only | Overweight | GBX 245→ GBX 290+18.4% |
|
Aug 12
09:55 UTC
|
INF
Informa
|
◎ Target | firm only | Buy | GBX 990→ GBX 1,090+10.1% |
|
Aug 12
09:55 UTC
|
HIK
Hikma Pharmaceuticals
|
◎ Target | firm only | Buy | GBX 1,700→ GBX 1,870+10.0% |
|
Aug 12
09:55 UTC
|
GLEN
Glencore
|
◎ Target | firm only | Buy | GBX 770→ GBX 780+1.3% |
|
Aug 12
09:55 UTC
|
GEN
Genuit Group
|
◎ Target | firm only | Overweight | GBX 440→ GBX 450+2.3% |
|
Aug 12
09:55 UTC
|
ELM
Elementis
|
◎ Target | firm only | Neutral | GBX 186→ GBX 190+2.2% |
|
Aug 12
09:55 UTC
|
DOM
Domino's Pizza Group
|
◎ Target | firm only | Underweight | GBX 145→ GBX 167+15.2% |
|
Aug 12
09:55 UTC
|
CLI
CLS
|
◎ Target | firm only | Buy | GBX 58→ GBX 51-12.1% |
|
Aug 12
09:55 UTC
|
BWY
Bellway
|
◎ Target | firm only | Buy | GBX 2,300→ GBX 2,500+8.7% |
|
Aug 12
09:55 UTC
|
BRBY
Burberry Group
|
◎ Target | firm only | Buy | GBX 1,560→ GBX 1,510-3.2% |
|
Aug 12
09:55 UTC
|
BGEO
Lion Finance Group
|
◎ Target | firm only | Overweight | £139→ £141+1.4% |
|
Aug 12
09:55 UTC
|
BBOX
Tritax Big Box REIT
|
◎ Target | firm only | Overweight | GBX 180→ GBX 190+5.6% |
|
Aug 12
09:55 UTC
|
ADM
Admiral Group
|
◎ Target | firm only | Sec→ r perform | GBX 3,450→ GBX 3,950+14.5% |
|
Aug 12
00:54 UTC
|
ZTS
Zoetis
|
◎ Target | Daniel Grosslight ★★★★☆ #874 | Buy | $112.00→ $96.00-14.3% |
|
Aug 12
00:54 UTC
|
ZTS
Zoetis
|
◎ Target | Navann Ty ★★☆☆☆ #2372 | Outperform | $146.00→ $110.00-24.7% |
|
Aug 12
00:54 UTC
|
ZG
Zillow Group
|
◎ Target | Dae Lee ★★★☆☆ #1725 | Overweight | $76.00→ $62.00-18.4% |
|
Aug 12
00:54 UTC
|
ZETA
Zeta Global
|
◎ Target | Ygal Arounian ★★☆☆☆ #2782 | Buy | $26.00→ $35.00+34.6% |
|
Aug 12
00:54 UTC
|
Z
Zillow Group
|
◎ Target | Dae Lee ★★★☆☆ #1725 | Overweight | $76.00→ $62.00-18.4% |
|
Aug 12
00:54 UTC
|
WSM
Williams-Sonoma
|
◎ Target | Zachary Fadem ★★★☆☆ #1899 | Equal Weight | $190.00→ $240.00+26.3% |
|
Aug 12
00:54 UTC
|
WH
Wyndham Hotels & Resorts
|
◎ Target | Christopher Stathoulopoulos ★★★☆☆ #1287 | Neutral | $90.00→ $80.00-11.1% |
|
Aug 12
00:54 UTC
|
WES
Western Midstream Partners
|
◎ Target | Spiro Dounis not yet tracked | Neutral | $42.00→ $45.00+7.1% |
|
Aug 12
00:54 UTC
|
WBTN
WEBTOON Entertainment
|
◎ Target | Dae Lee ★★★☆☆ #1725 | Neutral | $11.00→ $10.00-9.1% |
|
Aug 12
00:54 UTC
|
VTR
Ventas
|
◎ Target | Juan Sanabria not yet tracked | Outperform | $105.00→ $107.00+1.9% |
|
Aug 12
00:54 UTC
|
VSEC
VSE
|
◎ Target | Scott Deuschle ★★★★☆ #405 | Buy | $280.00→ $290.00+3.6% |
|
Aug 12
00:54 UTC
|
VOYA
Voya Financial
|
◎ Target | Ryan Krueger ★★★☆☆ #1202 | Outperform | $109.00→ $110.00+0.9% |
|
Aug 12
00:54 UTC
|
VOYA
Voya Financial
|
◎ Target | Pablo Singzon ★★★☆☆ #1681 | Neutral | $105.00→ $109.00+3.8% |
|
Aug 12
00:54 UTC
|
VLRS
Controladora Vuela Compania de Aviacion
|
◎ Target | Bruno Amorim ★★★★☆ #873 | Neutral | $8.60→ $7.70-10.5% |
|
Aug 12
00:54 UTC
|
VKTX
Viking Therapeutics
|
◎ Target | Hardik Parikh ★★☆☆☆ #2653 | Overweight | $75.00→ $65.00-13.3% |
|
Aug 12
00:54 UTC
|
VERA
Vera Therapeutics
|
◎ Target | Laura Chico ★★★☆☆ #2188 | Neutral | $43.00→ $34.00-20.9% |
|
Aug 12
00:54 UTC
|
URG
Ur Energy
|
◎ Target | Heiko F. Ihle not yet tracked | Buy | $2.30→ $2.20-4.3% |
|
Aug 12
00:54 UTC
|
UPWK
Upwork
|
◎ Target | Bernie McTernan ★★★★☆ #959 | Buy | $15.00→ $11.00-26.7% |
|
Aug 12
00:54 UTC
|
UPWK
Upwork
|
◎ Target | Nat Schindler ★★☆☆☆ #2492 | Sec→ r Perform | $10.00→ $8.00-20.0% |
|
Aug 12
00:54 UTC
|
UPWK
Upwork
|
◎ Target | Brad Erickson ★★☆☆☆ #2628 | Sec→ r Perform | $9.00→ $8.00-11.1% |
An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.
Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.
The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.
No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.